Psychedelic Therapy for Wellness Studies Retrospectively
This observational cohort study (n=100) aims to assess the efficacy of psychedelics, including psilocybin, MDMA, LSD, and ketamine, for improving measures of wellness.
Detailed Description
This retrospective cohort study will measure self-reported treatment effects of psychedelics on a composite wellness score combining patient global impression, mood, pain, function and disability measures.
Approximately 50 non-active military participants will be recruited via advertising to self-identify past therapeutic psychedelic use; data collection is a single survey including PGIC, PEG, HADS, DI and adverse-event history.
Study Arms & Interventions
Psychedelics
experimentalRetrospective self-report of past therapeutic use of psychedelics (psilocybin, MDMA, DMT, LSD, ketamine).
Interventions
- Compoundvia Other• retrospective survey
Self-reported past use of psilocybin, MDMA, DMT, LSD, ketamine; no dosing data; single-period cohort survey.
Participants
Inclusion Criteria
- 1. Between the ages of 18 - 99
- 2. Self-report of past psychedelic medicine use for therapeutic purposes in the last 3 years
- 3. While a consent letter will be provided, patients will only be asked to agree to the terms without providing their names (i.e., unsigned consent procedures) given the potential legal ramifications of identification
- 4. Civilian or military veterans.
Exclusion Criteria
- 1. Past psychedelic medicine use for non- therapeutic purposes
- 2. Only the most recent experience will be commented on
- 3. Active Military Members
- 4. Given the retrospective nature of the trial no other exclusion criteria outside not meeting the inclusion criteria are necessary.
- 5. In general patient participation will be anonymous given that access to medication may not have been considered legal. However in cases where there are concerns about a serious health issues and the patient can be identified, they will be to ensure appropriate follow up can be arranged.
Study Details
- StatusUnknown status
- PhasePhase NA
- Typeobservational
- DesignNon-randomized
- Target Enrollment100 participants
- TimelineStart: 2022-07-19End: 2025-08-18
- Topic